Qapital Research
Coverage
Companies we actively research and score. Each is rated through our eight-dimension signal model and monitored adaptively. A company earns coverage when we find asymmetry between quality and price. It earns Portfolio when the thesis clears the bar.
3
Companies Covered
0.00
Avg Gap Signal
0/3
Negative Gap
0/3
Favourable+
Coverage
3 companies · Last analysis -
Company
Vertical
Score
Gap
Rating
Price
LLYNYSE
Eli Lilly
BiotechGLP-1 / obesity
0/40
0.00
NEUTRAL
USD 1030.40
Signal within expected range
VRTXNASDAQ
Vertex Pharmaceuticals
BiotechGene editing / CF
0/40
0.00
NEUTRAL
USD 428.97
Signal within expected range
RXRXNASDAQ
Recursion Pharmaceuticals
BiotechAI drug discovery
0/40
0.00
NEUTRAL
USD 2.95
Signal within expected range
Gap = Actual Quality minus Perceived Quality. Negative gap signals potential overvaluation.
How we score →